Through enhanced CD36‐mediated hepatic free fatty acid absorption and CCl2‐induced inflammation because of increased chromatin accessibility in the Cd36 and Ccl2 promoter area, Mettl3‐specific deletion in hepatocytes promotes the development of NAFL to NASH. Here, METTL3 is linked to metabolic dysfunction-associated steatohepatitis.